<DOC>
	<DOCNO>NCT00946998</DOCNO>
	<brief_summary>This randomized double-blinded placebo-controlled trial see treatment sertraline compare placebo tablet improve depression symptom patient chronic kidney disease yet start dialysis receive kidney transplant . The investigator also investigate whether sertraline treatment improve quality life whether safe use patient kidney disease . The study subject randomly assign take either sertraline placebo tablet 12 week .</brief_summary>
	<brief_title>Chronic Kidney Disease Antidepressant Sertraline Trial</brief_title>
	<detailed_description>This randomized double-blinded placebo-controlled trial adult predialysis stag 3-5 Chronic Kidney Disease Major Depressive Episode . Subjects randomize double-blind fashion placebo sertraline ( begin 50 mg/d escalate 50 mg increment every 2 week maximum 200 mg/d ) follow 12 week . The primary outcome investigate treatment sertraline , compare placebo , result improvement depression symptom severity measure Quick Inventory Depressive Symptomatology Clinician Rated ( QIDS-C-16 ) score . Secondary outcome include whether sertraline , compare placebo , improve overall function quality life whether result serious adverse event .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Male female adult age great 21 year . Predialysis stag 3 , 4 5 CKD . Current Major Depressive Episode . QIDC16 score 11 . Able understand sign inform consent . No healthcare power attorney sign inform consent . Unwilling unable participate . Kidney transplant recipient . Initiated maintenance dialysis Significant hepatic dysfunction liver enzyme abnormalities 3 time upper limit normal . Terminal chronic obstructive pulmonary disease cancer . Recent history active bleeding , gastrointestinal bleeding require hospitalization 3 month prior Current use class I antiarrhythmic medication . Use pimozide , MAO inhibitor , reserpine , guanethidine , cimetidine methyldopa ; tricyclic antidepressant , neuroleptic anticonvulsant , exclude gabapentin Use serotonergic drug supplement triptans , tramadol , linezolid , tryptophan , St. John 's Wort . Ongoing use antidepressant Past treatment failure Sertraline Initiation psychotherapy depression 3 month prior study entry Alcohol substance abuse dependence require acute detoxification study entry Present past psychosis Bipolar I II disorder Dementia MiniMental State Examination score &lt; 23 Suicidal ideation Pregnancy , lactation woman childbearing potential use adequate contraception</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>Depression</keyword>
	<keyword>Antidepressants</keyword>
	<keyword>randomize control trial</keyword>
	<keyword>treatment</keyword>
	<keyword>Sertraline</keyword>
</DOC>